ClusPro BM5 Table1 antibody
Antibody-specific mode; Table1 does not explicitly label a masking condition. Do not infer masking from separate Figure3 experiments.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Model Capabilities & Hardware Requirements
Deployment facts recorded for ClusPro BM5 Table1 antibody. Fields the record does not carry are marked not recorded.
Evaluated Checkpoint: 2020 author configuration
Evaluations and results
4 evaluations · 40 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 7 CAPRI acceptable targets (all targets) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI medium targets (difficult (flexible) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 7 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 2 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 4 CAPRI medium targets (easy (rigid-body) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | N/A CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; intermediate column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 58.3% CAPRI top-10 success rate percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models % |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 10 CAPRI acceptable targets (all targets) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 CAPRI medium targets (difficult (flexible) targets; top 30 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 10 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 3 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 6 CAPRI medium targets (easy (rigid-body) targets; top 30 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | N/A CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; intermediate column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 83.3% CAPRI top-30 success rate percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models % |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 12 CAPRI acceptable targets (all targets) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI medium targets (difficult (flexible) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 11 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 6 CAPRI medium targets (easy (rigid-body) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; medium_accuracy_targets |
Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.
Use this configuration
How it works, versions and access
Related profile: ClusPro rigid-body docking. This page retains the exact record and its evaluation context.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Relationship: configuration of ucc-docking-cluspro-bm5-2020-method Individual claims | Performance and its limits in rigid body protein-protein docking Results and STAR Methods ClusPro Docking Server Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | source checked ["automated-source-review"] · 2026-09-30T21:50:23.483497+00:00 Audit detailsSource transcription only; not execution, human scientific review or independent reproduction. Field: Claim: ucc-docking-cluspro-bm5-2020-claim-config-antibody Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Performance and its limits in rigid body protein-protein docking · Original source · Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID ucc-docking-cluspro-bm5-2020-config-antibody.
Source locator: Results paragraph preceding Table1; STAR Methods ClusPro Docking Server
Related records
- configuration of: ClusPro rigid-body docking
- implemented by: ClusPro conventional docking baseline: Bound antibody
- implemented by: ClusPro conventional docking baseline: Unbound antibody
- subject: ClusPro antibody identity
- system: ClusPro Bound antibody top10
- system: ClusPro Bound antibody top30
- system: ClusPro Unbound antibody top10
- system: ClusPro Unbound antibody top30
How to cite
ClusPro BM5 Table1 antibody. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ucc-docking-cluspro-bm5-2020-config-antibody/
Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.
The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence